| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/16/2006 | US20060037102 Sugar and lipid metabolism regulators in plants IV |
| 02/16/2006 | US20060037098 found in proteasome regulatory subunits, eukaryotic initiation factor 3 (eIF3) subunits and regulators of transcription factors, comprising an amino acid sequence with at least 95 percent identity to protein isolated from Arabidopsis thaliana; used in controlling gene expression or for gene mapping |
| 02/16/2006 | US20060037097 Plant disease resistance genes |
| 02/16/2006 | US20060037095 Corn event TC1507 and methods for detection thereof |
| 02/16/2006 | US20060036090 efficient solid phase synthesis using a dimethoxytrityl (DMT) protected nucleoside succinate such as 5'-O-DMT-3'-O-succinyl uridine linked to a solid support such as controlled pore glass |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060036088 Natural promoters for gene expression in C1 metabolizing bacteria |
| 02/16/2006 | US20060036087 2'-deoxy-2'-fluoro modified RNA |
| 02/16/2006 | US20060036086 Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases |
| 02/16/2006 | US20060036085 Solution containing DNA in mixture with other components is passed over support on which is covalently coupled an pyrimidine-rich oligonucleotide capable of hybridizing with a specific sequence present on the DNA |
| 02/16/2006 | US20060036083 Ribosylated human neutrophil peptide-1or an ADP-ribosylated human neutrophil peptide-1; modified antimicrobial activity compared to alpha defensin lacking ADP-ribosylated or ribosylated residue; altered chemotaxis of T cells, altered neutrophil recruitment |
| 02/16/2006 | US20060036079 Surface protein of Leptospira |
| 02/16/2006 | US20060036078 Fluorescent proteins |
| 02/16/2006 | US20060036077 Gamma secretase substrates and in vitro assays |
| 02/16/2006 | US20060036074 Bromodomain protein |
| 02/16/2006 | US20060036028 Solid phase synthesis using a solid support prepared by polymerization of a polyarylmethyl-protected alkoxylated styrene monomer that has 2-10 oxyalkylene units |
| 02/16/2006 | US20060035856 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035855 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035835 Novel protein, production and use thereof |
| 02/16/2006 | US20060035813 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 02/16/2006 | US20060035366 Transglutaminase-producing strain |
| 02/16/2006 | US20060035363 Novel acylase gene |
| 02/16/2006 | US20060035362 Novel human hydrolase family members and uses thereof |
| 02/16/2006 | US20060035361 Novel cellulase tolerant to surfactants |
| 02/16/2006 | US20060035359 Survivin-binding proteins, encoding nucleic acids, and methods of use |
| 02/16/2006 | US20060035352 Production of 3-hydroxycarboxylic acid using nitrilase |
| 02/16/2006 | US20060035347 Polynucleotides encoding polypeptides involved in amino acid biosynthesis in Methylophilus methylotrophus |
| 02/16/2006 | US20060035343 The amino acid sequence corresponding to positions from 947 to 951 in a wild type carbamoylphosphate synthetase is replaced, and feedback inhibition by uridine 5'-monophosphate in the bacterium is desensitized |
| 02/16/2006 | US20060035342 Engineered enzymes and their use for synthesis of thioglycosides |
| 02/16/2006 | US20060035339 IL-8 like protein |
| 02/16/2006 | US20060035338 Method and apparatus for the production of soluble MHC antigens and uses thereof |
| 02/16/2006 | US20060035337 Leukocyte adhesion inhibitor-1 polypeptide for use in the treatment of cancer, tumors, chronic infections, leukemia, T-cell mediated auto-immune diseases, parasitic infections, psoriasis, asthma, allergy, to regulate hematopoiesis, to stimulate growth factor activity, to inhibit angiogenesis |
| 02/16/2006 | US20060035336 Prokaryotic collagen-like proteins and uses thereof |
| 02/16/2006 | US20060035334 Apo-2 receptor |
| 02/16/2006 | US20060035332 Novel RFRP-3 and DNA thereof |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035330 Non aggregating fluorescent proteins and methods for using the same |
| 02/16/2006 | US20060035329 Human hairless gene and protein |
| 02/16/2006 | US20060035328 Artery-and vein-specific proteins and uses therefor |
| 02/16/2006 | US20060035327 with changed spatial configuration and improved efficacy; preventing or treating viral diseases; antitumor agents; also an artificial gene which codes for the interferon |
| 02/16/2006 | US20060035326 Genes |
| 02/16/2006 | US20060035325 Regulated apoptosis |
| 02/16/2006 | US20060035324 BASB019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 02/16/2006 | US20060035323 Method for producing sweetners and alcohol |
| 02/16/2006 | US20060035322 T-cell epitopes in erythropoietin |
| 02/16/2006 | US20060035321 Hydantoin racemase |
| 02/16/2006 | US20060035320 Immunoglobulin frameworks which demonstrate enhanced statbility in the intracellular envioronment and methods of identifying same |
| 02/16/2006 | US20060035319 Introducing DNA sequence encoding heterologous antigenic peptide; elicits immunogenic response; vaccine against cervical cancer |
| 02/16/2006 | US20060035318 Teneurin c-terminal associated peptides (tcap) and uses thereof |
| 02/16/2006 | US20060035317 Effect of treatment with 4,5-dihydroxy-2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria |
| 02/16/2006 | US20060035316 Plasmids expressing human insulin and the preparation method for human insuling thereby |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060035314 Receptors and signalling proteins capable of binding meiotic acting sterols (MAS) |
| 02/16/2006 | US20060035312 nucleic acid molecules encoding enzymes useful for microbial production of cyclic hydroxylated carotenoid compounds; crtZ gene, isolated from Brevundimonas vesicularis DC263 |
| 02/16/2006 | US20060035286 Monitor protein for measuring processing of protein |
| 02/16/2006 | US20060035274 Complexity management of genomic DNA |
| 02/16/2006 | US20060035264 Processes for incorporating nucleic acid sequences into an analyte or library of analytes |
| 02/16/2006 | US20060035262 Dark quenchers for donor-acceptor energy transfer |
| 02/16/2006 | US20060035261 Selective restriction fragment amplification: fingerprinting |
| 02/16/2006 | US20060035260 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/16/2006 | US20060035257 Cleavage of nucleic acids |
| 02/16/2006 | US20060035254 Oligonucleotides comprising a modified or non-natural nucleobase |
| 02/16/2006 | US20060035251 Novel methods for high-throughput genome-wide location analysis |
| 02/16/2006 | US20060035238 Composition comprising an array which further comprises chimeric compositions |
| 02/16/2006 | US20060035236 DNA fingerprinting for Cannabis sativa (marijuana) using short tandem repeat (STR) markers |
| 02/16/2006 | US20060035233 Recovery of original template |
| 02/16/2006 | US20060035231 micro-channels have immobilized thereon a target molecule capable of binding to an analyte present in said sample; immobilized polynucleotides |
| 02/16/2006 | US20060035230 Bacterial effector proteins which inhibit programmed cell death |
| 02/16/2006 | US20060035224 Purification methods for oligonucleotides and their analogs |
| 02/16/2006 | US20060035219 Aberrant kallikrein expression |
| 02/16/2006 | US20060035218 For in situ synthesis of oligonucleotide fragments on a solid phase microarray platform and subsequent, "on device" assembly of larger polynucleotides composed of a plurality of shorter oligonucleotide fragments |
| 02/16/2006 | US20060035217 Binary probe and clamp composition. |
| 02/16/2006 | US20060035216 recombinant nucleic acid; isotopic, fluorescent, chemiluminescent, enzymatic, or hapten probe; cloning vector of the nucleic acid; host cell with improved exogenous expression of the nucleic acid; biodegradation; pollution control |
| 02/16/2006 | US20060034866 Adipocyte complement related protein homolog zacrp3 |
| 02/16/2006 | US20060034861 HCV E1 comprising specific disulfide bridges |
| 02/16/2006 | US20060034860 Protein-protein interactions in human immunodeficiency virus |
| 02/16/2006 | US20060034859 Naturally processed measles virus peptides eluted from class II HLA molecules |
| 02/16/2006 | US20060034858 A beta or an immunogenic fragment thereof presented by a virus or bacteria as part of an immunogenic composition effective to induce an immunogenic response comprising antibodies against A beta |
| 02/16/2006 | US20060034853 Novel human virus causing respiratory tract infection and uses thereof |
| 02/16/2006 | US20060034850 Antibodies as T cell receptor mimics, methods of production and uses thereof |
| 02/16/2006 | US20060034843 Interaction of Smad6 with Hox proteins and uses thereof |
| 02/16/2006 | US20060034835 Immunoglobulin variants and uses thereof |
| 02/16/2006 | US20060034830 Immunoglobulins comprising predominantly a GalGlcNAcMan5GLcNAc2 glycoform |
| 02/16/2006 | US20060034829 Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoform |
| 02/16/2006 | US20060034828 glycoproteins; glycans; increased antibody-dependent cellular cytotoxicity (ADCC) activity; kits |
| 02/16/2006 | DE102004034474A1 Vorrichtung und Verfahren zur effizienteren Isolierung von Nukleinsäuren Apparatus and method for efficient isolation of nucleic acids |
| 02/16/2006 | CA2577141A1 Compositions and methods for determining and predicting treatment responses for depression and anxiety |
| 02/16/2006 | CA2573656A1 Aav vector compositions and methods for enhanced expression of immunoglobulins using the same |
| 02/16/2006 | CA2573368A1 Improved aprotinin variants |
| 02/16/2006 | CA2571650A1 Identification of makers in esophageal cancer, colon cancer, head and neck cancer and melanoma |
| 02/15/2006 | EP1626086A2 Double-stranded nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
| 02/15/2006 | EP1625235A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis |
| 02/15/2006 | EP1625232A2 Internal control nucleic acid molecule for nucleic acid amplification systems |
| 02/15/2006 | EP1625228A1 Methods and compositions for detecting sars virus |
| 02/15/2006 | EP1625223A2 Chemoenzymatic methods for the synthesis of statins and statin intermediates |
| 02/15/2006 | EP1625209A2 Immunoglobulin chimeric monomer-dimer hybrids |
| 02/15/2006 | EP1625208A2 Novel lipolytic enzyme lip2 |
| 02/15/2006 | EP1625206A2 siRNA INDUCED SYSTEMIC GENE SILENCING IN MAMMALIAN SYSTEMS |
| 02/15/2006 | EP1625205A2 Ancestral viruses and vaccines |
| 02/15/2006 | EP1625204A2 Genes encoding carotenoid compounds |